Karyopharm Therapeutics Inc. (KPTI)
NASDAQ·Healthcare·Biotechnology
$0.04
-28.94%
Mkt Cap $1.65M
Analyst Ratings
Buy
1
Hold
2
Sell
0
Price Target (16 analysts)
$13.20
Range $3.00 – $28.00
Implied Upside
+33317.7%
Consensus $13.20 vs current $0.04
NASDAQ·Healthcare·Biotechnology
$0.04
-28.94%
Mkt Cap $1.65M
Buy
1
Hold
2
Sell
0
Price Target (16 analysts)
$13.20
Range $3.00 – $28.00
+33317.7%
Consensus $13.20 vs current $0.04